Table 1.
Tumor incidence and size-based indication of tumors in the experimental groups.
| Males | Females | |||||
|---|---|---|---|---|---|---|
| WT | Ripk3 −/− | Mlkl −/− | WT | Ripk3 −/− | Mlkl −/− | |
| Tumor incidence | 100% (10/10) | 75% (6/8) | 100% (7/7) | 87.5% (7/8) | 80% (4/5) | 75% (3/4) |
| Small sized tumors: <0.1 mm | 10.36 ± 1.86, | 2.86 ± 1.01, | 6.14 ± 1.32, | 4.42 ± 0.66, | 2.2 ± 0.66, | 1.25 ± 0.48, |
| (number and percentage) | 68% | 80% | 87% | 90% | 92% | 64% |
| Medium sized tumors: 2–4 mm | 3 ± 1.27, | 0.625 ± 0.42, | 0.33 ± 0.21, | 0.42 ± 0.23, | 0.2 ± 0.2, | 0.75 ± 0.7, |
| (number and percentage) | 20% | 20% | 5% | 9% | 8% | 36% |
| Large sized tumors: >5 mm | 1.88 ± 1.28, | 0 | 0.57 ± 0.297, | 0.1 ± 0.1, | 0,0 | 0,0 |
| (number and percentage) | 12% | 0 | 8% | 2% | ||